These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 5987279)
1. [The possibility of local cytostatic therapy]. Grundmann E HNO; 1966 May; 14(5):129-33. PubMed ID: 5987279 [No Abstract] [Full Text] [Related]
2. [Intensification of cytostatic action by radiosensitizers--a review of the present status of chemosensitization]. Moldenhauer H; Rose H; Saul G; Wolf G; Kehrberg G Radiobiol Radiother (Berl); 1984; 25(2):289-95. PubMed ID: 6234615 [No Abstract] [Full Text] [Related]
3. Experimental cancer chemotherapy: strategy for cure. Cain BF N Z Med J; 1971 Feb; 73(465):85-90. PubMed ID: 4994879 [No Abstract] [Full Text] [Related]
5. [Transferability of animal experiment results to cytostatic chemotherapy on humans]. Karrer K Adv Clin Pharmacol; 1977; 14():89-97. PubMed ID: 596276 [No Abstract] [Full Text] [Related]
6. Phase I and II studies of cytostatic hexitol derivatives: the role of alkylating metabolites? Eckhardt S; Kerpel-Fronius S; Horváth IP; Institoris L Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):783-8. PubMed ID: 3985644 [No Abstract] [Full Text] [Related]
7. [Side-effects of cytostatic therapy with special reference to potential carcinogenic effects]. Schmähl D Internist (Berl); 1971; 12():Suppl 1:115-9. PubMed ID: 5002614 [No Abstract] [Full Text] [Related]
8. [Cytostatic treatment of plasmacytoma]. Günther I; Gladitz G Z Gesamte Inn Med; 1972 Nov; 27(21):933-7. PubMed ID: 4662918 [No Abstract] [Full Text] [Related]
9. [On ways of reducing the toxic effects of antitumorous preparations]. Monakhov BV Vopr Onkol; 1968; 14(8):101-12. PubMed ID: 4301862 [No Abstract] [Full Text] [Related]
10. Topical use of cancerocidal agents in an experimental model. Zwaveling A; Vroom EM Arch Chir Neerl; 1966; 18(4):273-82. PubMed ID: 5971515 [No Abstract] [Full Text] [Related]
11. Antitumor drug toxicity: implications for response and for survival. Nahhas WA; Hall TC; Sherman CD; Savlov ED Am J Med Sci; 1969 Oct; 258(4):245-59. PubMed ID: 5823461 [No Abstract] [Full Text] [Related]
12. [Experimental research on the antineoplastic activity of osaĭin]. Shvarev IF; Tsetlin AL; Nikol'skaia BS; Nikonov GK Vopr Onkol; 1966; 12(3):64-6. PubMed ID: 5991963 [No Abstract] [Full Text] [Related]
13. [Oncobiogram and its significance in the choice and efficacy of cytostatic therapy]. Savran VR Vopr Onkol; 1983; 29(3):106-13. PubMed ID: 6340347 [No Abstract] [Full Text] [Related]
14. [Lysosomes and problems of therapy of malignant tumors]. Filov VA Vopr Onkol; 1970; 16(7):93-100. PubMed ID: 4921613 [No Abstract] [Full Text] [Related]
15. [Segidrin: a new-type antineoplastic agent]. Filov VA Vopr Onkol; 1994; 40(1-3):3-14. PubMed ID: 7701790 [No Abstract] [Full Text] [Related]
16. [Overview on chemotherapy of cancer: discussion]. Koyama Y; Ota K; Ogawa K; Saito T; Taguchi T Gan To Kagaku Ryoho; 1982 Jan; 9(1):7-25. PubMed ID: 7184363 [No Abstract] [Full Text] [Related]
17. [Cytostatic effect of resochin and atebrin (compare same journal 20 (N.F.) 28: 1591 (1969))]. Nieper HA Med Welt; 1970 May; 22():1047-8. PubMed ID: 5509757 [No Abstract] [Full Text] [Related]
18. Experimental approach for the search of effective drug combination in cancer chemotherapy. Bello JL; Kariev NI; Mainardi JV; Betancourt M; Lage A; Barroso MC; Alfonso L Neoplasma; 1982; 29(1):65-71. PubMed ID: 7070556 [TBL] [Abstract][Full Text] [Related]
19. [Drug therapy in pulmonary neoplasms]. Cairella M; Marasà G Clin Ter; 1970 Jul; 54(2):163-79. PubMed ID: 5476350 [No Abstract] [Full Text] [Related]